The molecular genetics of coenzyme Q biosynthesis in health and disease

被引：54
作者：
Laredj, Leila N. [1 ,2 ,3 ,4 ,5 ]
Licitra, Floriana [1 ,2 ,3 ,4 ,5 ]
Puccio, Helene M. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] IGBMC, Illkirch Graffenstaden, France
[2] INSERM, U596, Illkirch Graffenstaden, France
[3] CNRS, UMR 7104, Illkirch Graffenstaden, France
[4] Univ Strasbourg, Strasbourg, France
[5] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France
来源：
BIOCHIMIE | 2014年 / 100卷
基金：
欧洲研究理事会;
关键词：
Coenzyme Q; Mitochondria; Mouse models; Ataxia; Lipid metabolism; O-METHYLTRANSFERASE STEPS; SACCHAROMYCES-CEREVISIAE; CEREBELLAR-ATAXIA; PARA-HYDROXYBENZOATE; NEPHROTIC SYNDROME; UBIQUINONE BIOSYNTHESIS; MITOCHONDRIAL PROTEIN; Q(10) SUPPLEMENTATION; EMBRYONIC-DEVELOPMENT; MULTISUBUNIT COMPLEX;
D O I：
10.1016/j.biochi.2013.12.006
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Coenzyme Q or ubiquinone, is an endogenously synthesized lipid-soluble antioxidant that plays a major role in the mitochondrial respiratory chain. Although extensively studied for decades, recent data on coenzyme Q have painted an exciting albeit incomplete picture of the multiple facets of this molecule's function. In humans, mutations in the genes involved in the biosynthesis of coenzyme Q lead to a heterogeneous group of rare disorders, with most often severe and debilitating symptoms. In this review, we describe the current understanding of coenzyme Q biosynthesis, provide a detailed overview of human coenzyme Q deficiencies and discuss the existing mouse models for coenzyme Q deficiency. Furthermore, we briefly examine the current state of affairs in non-mitochondrial coenzyme Q functions and the latter's link to statin. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：78 / 87
页数：10
相关论文
共 101 条
[21]   Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro [J].
Flint, OP ;
Masters, BA ;
Gregg, RE ;
Durham, SK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :91-98
[22]   HMG CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture [J].
Flint, OP ;
Masters, BA ;
Gregg, RE ;
Durham, SK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :99-110
[23]  
Forsman U, 2010, NAT CHEM BIOL, V6, P515, DOI [10.1038/NCHEMBIO.372, 10.1038/nchembio.372]
[24]   Ectopic expression of the TERE1 (UBIAD1) protein inhibits growth of renal clear cell carcinoma cells: Altered metabolic phenotype associated with reactive oxygen species, nitric oxide and SXR target genes involved in cholesterol and lipid metabolism [J].
Fredericks, William J. ;
Yin, Hankun ;
Lal, Priti ;
Puthiyaveettil, Raghunath ;
Malkowicz, Stephen B. ;
Fredericks, Nathaniel J. ;
Tomaszewski, John ;
Rauscher, Frank J., III ;
Malkowicz, S. Bruce .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (02) :638-652
[25]  
Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022
[26]   Lipid-lowering drugs and risk of myopathy:: A population based follow-up study [J].
Gaist, D ;
Rodríguez, LAG ;
Huerta, C ;
Hallas, J ;
Sindrup, SH .
EPIDEMIOLOGY, 2001, 12 (05) :565-569
[27]   Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency [J].
Garcia-Corzo, Laura ;
Luna-Sanchez, Marta ;
Doerrier, Carolina ;
Garcia, Jose A. ;
Guaras, Adela ;
Acin-Perez, Rebeca ;
Bullejos-Peregrin, Javier ;
Lopez, Ana ;
Escames, Germaine ;
Enriquez, Jose A. ;
Acuna-Castroviejo, Dario ;
Lopez, Luis C. .
HUMAN MOLECULAR GENETICS, 2013, 22 (06) :1233-1248
[28]   Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and atrophy [J].
Gerards, Mike ;
van den Bosch, Bianca ;
Calis, Chantal ;
Schoonderwoerd, Kees ;
van Engelen, Klaartje ;
Tijssen, Marina ;
de Coo, Rene ;
van der Kooi, Anneke ;
Smeets, Hubert .
MITOCHONDRION, 2010, 10 (05) :510-515
[29]  
Gibson F, 1978, Methods Enzymol, V53, P600
[30]  
Gibson F, 1973, Essays Biochem, V9, P1
12345678910